Homeresearch

research

biotech

Vedana Therapeutics launches to develop migraine therapies

Jim Cornall - June 25, 2026

biotech

Memento Medicines launches with $93m to develop antibody therapy for retinal diseases

Jim Cornall - June 25, 2026

biotech

Meteor Biotech joins brain organoids consortium

Jim Cornall - June 25, 2026

biotech

Can food influence gene activity?

Jim Cornall - June 24, 2026

photonics

Super photon research could lead to tap-proof communication

Jim Cornall - September 6, 2024

photonics

Lighting the way for quantum innovation

Jim Cornall - August 30, 2024

research

Paving the way for improved fuel cell vehicles

Jim Cornall - August 14, 2024

biotech

European Inventor Award 2024 finalists revealed

Jim Cornall - May 29, 2024

energy

Researchers hail solar cell technology advancement

Jim Cornall - May 15, 2024

AI

Boost for security in artificial intelligence and image processing

Jim Cornall - April 29, 2024

research

New opportunities for 2D material

Jim Cornall - March 15, 2024

research

A “quantum leap” at room temperature

Jim Cornall - February 16, 2024

1...345 Page 4 of 5

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Vedana Therapeutics launches to develop migraine therapies

Jim Cornall - June 25, 2026 0

Vedana Therapeutics, a biotechnology company developing next-generation therapies for migraine prevention, has emerged from stealth with $46m in Series A financing. The financing was co-led...

Memento Medicines launches with $93m to develop antibody therapy for retinal diseases

biotech Jim Cornall - June 25, 2026 0

Meteor Biotech joins brain organoids consortium

biotech Jim Cornall - June 25, 2026 0

Can food influence gene activity?

biotech Jim Cornall - June 24, 2026 0

Lab-engineered proteins: a promising treatment for liver disease

biotech Jim Cornall - June 24, 2026 0